This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Half-year results approved; operating cash flow positive
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.6 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone results for the half-year ended 30 September 2026 were approved by the board; no consolidated results were filed. Net cash from operating activities was Rs 1,070 lakh, and the cash flow statement is labelled restated. The filing reports no exceptional items, and the reviewers raised no material concern. Revenue and profit figures are not legible in the supplied text, and no quarterly comparison is provided.
Positive operating cash flow supports financial stability, but missing revenue and profit figures leave the earnings direction unclear.
| Q2 FY27 | Year ago | Change | |
|---|---|---|---|
| Revenue | ₹51.88 Cr | — | — |
| Operating profit | ₹11.11 Cr | — | — |
| Profit after tax | ₹7.78 Cr | — | — |
| EBITDA margin | 29.4% | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income. No year-ago figures on this basis yet, so no comparison.